ClinicalTrials.gov
ClinicalTrials.gov Menu

A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01393587
Recruitment Status : Unknown
Verified July 2011 by Western Galilee Hospital-Nahariya.
Recruitment status was:  Not yet recruiting
First Posted : July 13, 2011
Last Update Posted : July 18, 2012
Sponsor:
Collaborator:
Migal, Galilee Technology Center
Information provided by:
Western Galilee Hospital-Nahariya

Brief Summary:

Recently, a new synthetic marker was developed, based on a molecule that is composed of Amino Acids and Linoleic Acid and Neucleic Acid, which is capable of detecting even minor changes of oxidative stress.

The investigators would like to assess the usefulness of this marker during positive pressure pneumoperitoneum, during laproscopic surgery, with or without intenstinal resection (ischemia induced by intra-abdominal pressure and vascualr compromise).


Condition or disease Intervention/treatment Phase
Oxidative Stress Laproscopy Procedure: Taking blood samples Not Applicable

Study Type : Interventional  (Clinical Trial)
Official Title: A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

Arm Intervention/treatment
Experimental: Experimental Procedure: Taking blood samples




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy patients undergoing elective laproscopic cholecystectomy and patients undergoing operation for tumer of large intenstine.

Exclusion Criteria:

  • Patients suffering from Cardio Pulmonory and renal diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01393587


Contacts
Contact: Amitai Bickel, Dr. +972-507887554 ext 7554 amitai@netvision.net.il
Contact: Y Mosenzon, M.A +972-49107011 ext 7022 yael.mosenzon@naharia.health.gov.il

Locations
Israel
Western Galilee Hospital Not yet recruiting
Nahariya, Israel, 22100
Principal Investigator: Amitai Bickel, Dr.         
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
Migal, Galilee Technology Center

ClinicalTrials.gov Identifier: NCT01393587     History of Changes
Other Study ID Numbers: BIC-2011
First Posted: July 13, 2011    Key Record Dates
Last Update Posted: July 18, 2012
Last Verified: July 2011

Keywords provided by Western Galilee Hospital-Nahariya:
Oxidative Stress
Laproscopy